Natural products as a source of novel drugs for treating SARS-CoV2 infection

10.1016/j.jtcme.2022.02.001

Ciro Isidoro；Ashley Chiung-Fang Chang；Lee-Yan Sheen

Infectious disease ； Viral replication ； Nutraceuticals ； Herbal medicine ； Dietary supplements ； Molecular docking ； Drug development

Journal of Traditional and Complementary Medicine

12卷1期（2022 / 01 / 01）

1 - 5

英文

COVID-19, the infectious disease caused by the beta-corona virus SARS-CoV2, has posed a global health threat causing more than five million of deaths in the last two years in the world. Although the disease often presents with mild cold-like symptoms, it may have lethal consequences following thromboembolisms hyperinflammation and cytokine storm eventually leading to pulmonary fibrosis and multiple organ failure. Despite the progress made in the understanding of the SARS-CoV2 pathology and the clinical management of COVID-19, the viral illness is still a health concern since outbreaks continue to resurge due to the emergence of mutant variants of the virus that resist the vaccines. Therefore, there is an urgent need for therapeutics that can block SARS-CoV2 viral transmission and the progression from infection to severe symptomatic illness. Natural products could be a valuable source of drugs for the management of COVID-19 disease, particularly because they can act on multitargets and through different mechanisms including inhibition of biochemical pathways, epigenetic regulation of gene expression, modulation of immune response, regulation of pathophysiological stress response. Here we present an overview of the natural products that possess SARS-CoV2 antiviral activity and the potential to benefit the management of COVID-19.

1. Chen, G-Y(2021).Potential natural products that target the SARS-CoV-2 spike protein identified by structure-based virtual screening, isothermal titration calorimetry and lentivirus particles pseudotyped (Vpp) infection assay.J Tradit Complement Med
   連結：
2. Isidoro, C,Huang, CC,Sheen, LY(2016).Publishing scientifically sound papers in traditional and complementary medicine.J Tradit Complement Med,16(1),1-4.
   連結：
3. Kumar, A(2022).Role of Herbal Medicines in the Management of Patients with COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Journal of Traditional and Complementary Medicine
   連結：
4. Panyod, S,Ho, C-T,Sheen, L-Y(2020).Dietary therapy and herbal medicine for COVID-19 prevention: a review and perspective.J Tradit Complement Med,10(4),420-427.
   連結：
5. Prasansuklab, A(2021).Anti-COVID-19 drug candidates: a review on potential biological activities of natural products in the management of new coronavirus infection.J Tradit Complement Med,11(2),144-157.
   連結：
6. Rahman, F(2021).Molecular docking analysis of rutin reveals possible inhibition of SARS-CoV-2 vital proteins.J Tradit Complement Med,11(2),173-179.
   連結：
7. Rangsinth, P(2021).Mushroom-derived bioactive compounds potentially serveas the inhibitors of SARS-CoV-2 main protease: an in silico approach.J Tradit Complement Med,11(2),158-172.
   連結：
8. Singh, P(2021).The dual role of phytochemicals on SARS-CoV-2 inhibition by targeting host and viral proteins.J Tradit Complement Med
   連結：
9. Singh, R(2021).In-silico evaluation of bioactive compounds from tea as potential SARS-CoV-2 nonstructural protein 16 inhibitors.J Tradit Complement Med
   連結：
10. Tanikawa, T(2021).Inhibitory effect of honokiol on furin-like activity and SARS-CoV-2 infection.J Tradit Complement Med
    連結：
11. Vardhan, S,Sahoo, S-K(2021).Exploring the therapeutic nature of limonoids and triterpenoids against SARS-CoV-2 by targeting nsp 13, nsp14, and nsp15 through molecular docking and dynamics simulations.J Tradit Complement Med
    連結：
12. Vardhan, S,Sahoo, S-K(2021).Virtual screening by targeting proteolytic sites of furin and TMPRSS2 to propose potential compounds obstructing the entry of SARS-CoV-2 virus into human host cells.J Tradit Complement Med
    連結：
13. Vidoni, C(2021).Targeting autophagy with natural products to prevent SARSCoV-2 infection.J Tradit Complement Med
    連結：
14. Zaki, A-A(2021).Calendula glycoside A showing potential activity against SARS-CoV-2 main protease: molecular docking, molecular dynamics, and SAR studies.J Tradit Complement Med
    連結：
15. Zhu, Y-W(2021).Analyzing the potential therapeutic mechanism of Huashi Baidu Decoction on severe COVID-19 through integrating network pharmacological methods.J Tradit Complement Med,11(2),180-187.
    連結：
16. Ali, S(2022).Natural products can be used in therapeutic management of COVID-19: probable mechanistic insights.Biomed Pharmacother,147,112658.
17. Brendler(2021).Botanical drugs and supplements affecting the immune response in the time of COVID-19: implications for research and clinical practice.Phytother Res,35,3013-3031.
18. Chen, J(2021).,未出版
19. Chong, WC(2021).An appraisal of the current scenario in vaccine research for COVID-19.Viruses,13(7),1397.
20. Colunga Biancatelli, RML(2020).Quercetin and vitamin C: an experimental, synergistic therapy for the prevention and treatment of SARS-CoV-2 related disease (COVID-19).Front Immunol,11,1451.
21. da Silva, Priscilla(2021).Fighting coronaviruses with natural polyphenols.Biocatal Agric Biotechnol,37(5),102179.
22. Dai, YJ(2020).Recent advances of traditional Chinese medicine on the prevention and treatment of COVID-19.Chin J Nat Med.,18(12),881-889.
23. Domingo, P(2020).The four horsemen of a viral apocalypse: the pathogenesis of SARS-CoV-2 infection (COVID-19).EBioMedicine,58,102887.
24. Fuzimoto, AD,Isidoro, C(2020).The antiviral and coronavirus-host protein pathways inhibiting properties of herbs and natural compounds - additional weapons in the fight against the COVID-19 pandemic?.J Tradit Complement Med,10(4),405-419.
25. Jan, Jia-Tsrong(2021).Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection.Proc Natl Acad Sci Unit States Am.,118(5),e2021579118.
26. Lalvani, A(2022).Transmissibility of SARS-CoV-2 among fully vaccinated individuals.Lancet,22,18-19.
27. Lee, Yuan Yee(2022).COVID-19 and Panax ginseng: targeting platelet aggregation, thrombosis and the coagulation pathway.J Ginseng Res
28. Li, J(2021).The emergence, genomic diversity and global spread of SARS-CoV-2.Nature,600,408-418.
29. Lu, R(2020).Genomic characterisation and epidemiology of 2019 novel corona-virus: implications for virus origins and receptor binding.Lancet,395,565-574.
30. Luo(2021).Characteristics of registered clinical trials on traditional Chinese medicine for coronavirus disease 2019 (COVID-19): a scoping review.Eur J Integr Med,41,101251.
31. Monticolo(2020).A web resource to collect natural compounds against human coronaviruses.Trends Food Sci Technol,106,1-11.
32. Mrityunjaya, M(2020).Immune-boosting, antioxidant and anti-inflammatory food supplements targeting pathogenesis of COVID-19.Front Immunol,11,570122.
33. Muhammad, S,Hassan, SH,Al-Sehemi, AG(2021).Exploring the new potential antiviral constituents of Moringa oliefera for SARS-COV-2 pathogenesis: an in silico molecular docking and dynamic studies.Chem Phys Lett,767
34. Noori, M(2021).Potency of BNT162b2 and mRNA-1273 vaccine-induced neutralizing antibodies against severe acute respiratory syndrome-CoV-2 variants of concern: a systematic review of in vitro studies.Rev Med Virol,e2277.
35. Nowill, AE(2020).Immune response resetting as a novel strategy to overcome SARS-CoV-2-induced cytokine storm.J Immunol,205,2566-2575.
36. Peter, Angela E(2021).Calming the storm: natural immunosuppressants as adjuvants to target the cytokine storm in COVID-19.Front Pharmacol
37. Runfeng, L(2020).Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2).Pharmacol Res.,156,104761.
38. Selvaraj, J,Rekha, UV,Jh, SF(2021).Molecular docking analysis of SARS-CoV-2 linked RNA dependent RNA polymerase (RdRp) with compounds from Plectranthus amboinicus.Bioinformation,17(1),167-170.
39. Shi, N(2021).Efficacy and safety of Chinese herbal medicine versus LopinavirRitonavir in adult patients with coronavirus disease 2019: a non-randomized controlled trial.Phytomedicine,81,153367.
40. Shu, Z(2021).Add-on Chinese medicine for coronavirus disease 2019 (ACCORD): a retrospective cohort study of hospital registries.Am J Chin Med,49(3),543-575.
41. Sun, Jing(2021).Association between immune dysfunction and COVID-19 breakthrough infection after SARS-CoV-2 vaccination in the US.JAMA Intern Med,28,e217024.
42. Wang, Q(2022).Longitudinal Waning of mRNA Vaccine-Induced Neutralizing Anti-bodies against SARS-CoV-2 Detected by an LFIA Rapid Test.Antibody Therapeutics,tbac004.
43. Xu, H(2021).Computational and experimental studies reveal that thymoquinone blocks the entry of coronaviruses into in vitro cells.Infect Dis Ther,10(1),483-494.
44. Yu, Mei-Xiang(2021).Investigation into molecular mechanisms and highfrequency core TCM for pulmonary fibrosis secondary to COVID-19 based on network pharmacology and data mining.Ann Palliat Med,10(4),3960-3975.
45. Yu, R(2022).A systematic review of outcomes in COVID-19 patients treated with western medicine in combination with traditional Chinese medicine versus western medicine alone.Expet Rev Mol Med,24,e5.
46. Zhang, Mengxin(2022).A systematic review of vaccine breakthrough infections by SARS-CoV-2 delta variant.Int J Biol Sci.,18(2),889-900.
47. Zhang, S(2022).Efficacy and safety of "three Chinese patent medicines and three TCM prescriptions" for COVID-19: a systematic review and network meta-analysis.Evid Based Complement Alternat Med,2022,4654793.
48. Zhou, P(2020).A pneumonia outbreak associated with a new coronavirus of probable bat origin.Nature,59,270-273.